Your browser doesn't support javascript.
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2.
Popa, Alexandra; Genger, Jakob-Wendelin; Nicholson, Michael D; Penz, Thomas; Schmid, Daniela; Aberle, Stephan W; Agerer, Benedikt; Lercher, Alexander; Endler, Lukas; Colaço, Henrique; Smyth, Mark; Schuster, Michael; Grau, Miguel L; Martínez-Jiménez, Francisco; Pich, Oriol; Borena, Wegene; Pawelka, Erich; Keszei, Zsofia; Senekowitsch, Martin; Laine, Jan; Aberle, Judith H; Redlberger-Fritz, Monika; Karolyi, Mario; Zoufaly, Alexander; Maritschnik, Sabine; Borkovec, Martin; Hufnagl, Peter; Nairz, Manfred; Weiss, Günter; Wolfinger, Michael T; von Laer, Dorothee; Superti-Furga, Giulio; Lopez-Bigas, Nuria; Puchhammer-Stöckl, Elisabeth; Allerberger, Franz; Michor, Franziska; Bock, Christoph; Bergthaler, Andreas.
  • Popa A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Genger JW; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Nicholson MD; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Penz T; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Schmid D; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
  • Aberle SW; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Agerer B; Austrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
  • Lercher A; Center for Virology, Medical University of Vienna, 1090 Vienna, Austria.
  • Endler L; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Colaço H; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Smyth M; Bioinformatics and Biostatistics Platform, Department of Biomedical Sciences, University of Veterinary Medicine, 1210 Vienna, Austria.
  • Schuster M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Grau ML; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Martínez-Jiménez F; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Pich O; Institute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.
  • Borena W; Institute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.
  • Pawelka E; Institute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.
  • Keszei Z; Institute of Virology, Medical University Innsbruck, 6020 Innsbruck, Austria.
  • Senekowitsch M; Department of Medicine IV, Kaiser Franz Josef Hospital, 1100 Vienna, Austria.
  • Laine J; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Aberle JH; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Redlberger-Fritz M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Karolyi M; Center for Virology, Medical University of Vienna, 1090 Vienna, Austria.
  • Zoufaly A; Center for Virology, Medical University of Vienna, 1090 Vienna, Austria.
  • Maritschnik S; Department of Medicine IV, Kaiser Franz Josef Hospital, 1100 Vienna, Austria.
  • Borkovec M; Department of Medicine IV, Kaiser Franz Josef Hospital, 1100 Vienna, Austria.
  • Hufnagl P; Austrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
  • Nairz M; Austrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
  • Weiss G; Austrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
  • Wolfinger MT; Department of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • von Laer D; Department of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Superti-Furga G; Department of Theoretical Chemistry, University of Vienna, 1090 Vienna, Austria.
  • Lopez-Bigas N; Research Group Bioinformatics and Computational Biology, Faculty of Computer Science, University of Vienna, 1090 Vienna, Austria.
  • Puchhammer-Stöckl E; Institute of Virology, Medical University Innsbruck, 6020 Innsbruck, Austria.
  • Allerberger F; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Michor F; Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
  • Bock C; Institute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.
  • Bergthaler A; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Sci Transl Med ; 12(573)2020 12 09.
Article in English | MEDLINE | ID: covidwho-940793
ABSTRACT
Superspreading events shaped the coronavirus disease 2019 (COVID-19) pandemic, and their rapid identification and containment are essential for disease control. Here, we provide a national-scale analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) superspreading during the first wave of infections in Austria, a country that played a major role in initial virus transmissions in Europe. Capitalizing on Austria's well-developed epidemiological surveillance system, we identified major SARS-CoV-2 clusters during the first wave of infections and performed deep whole-genome sequencing of more than 500 virus samples. Phylogenetic-epidemiological analysis enabled the reconstruction of superspreading events and charts a map of tourism-related viral spread originating from Austria in spring 2020. Moreover, we exploited epidemiologically well-defined clusters to quantify SARS-CoV-2 mutational dynamics, including the observation of low-frequency mutations that progressed to fixation within the infection chain. Time-resolved virus sequencing unveiled viral mutation dynamics within individuals with COVID-19, and epidemiologically validated infector-infectee pairs enabled us to determine an average transmission bottleneck size of 103 SARS-CoV-2 particles. In conclusion, this study illustrates the power of combining epidemiological analysis with deep viral genome sequencing to unravel the spread of SARS-CoV-2 and to gain fundamental insights into mutational dynamics and transmission properties.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Mutation Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Science / Medicine Year: 2020 Document Type: Article Affiliation country: Scitranslmed.abe2555

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Mutation Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Science / Medicine Year: 2020 Document Type: Article Affiliation country: Scitranslmed.abe2555